tiprankstipranks

Top UK Pharma & Biotech Shares

Compare UK pharmaceutical companies and biotech shares. See a comparison of key indicators, including pharma stock price targets and analyst recommendations.
Compare up to 10 stocks or ETFs

Comparison Results

Name
Price
Price Change
Volume
Market Cap
Analyst Price Target
Analyst Consensus
Smart Score
Article
Follow
GB:AZN
AstraZeneca
12081.00p
51p
(0.42%)
161.29K£188.60B
11 Buy
4 Hold
1 Sell
Moderate Buy
GB:GSK
GlaxoSmithKline
1771.75p
8.25p
(0.46%)
808.84K£72.73B
8 Buy
4 Hold
2 Sell
Moderate Buy
GB:HIK
Hikma Pharmaceuticals
1984.00p
5p
(0.25%)
22.91K£4.40B
2 Buy
5 Hold
0 Sell
Moderate Buy
GB:HCM
HUTCHMED (China) Limited
337.00p
3p
(0.88%)
43.52K£2.95B
2 Buy
0 Hold
0 Sell
Moderate Buy
GB:DPH
DPH

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
GB:AZN
AstraZeneca
12,166.00
448.69
3.83%
GB:GSK
GlaxoSmithKline
1,783.50
413.28
30.16%
GB:HIK
Hikma Pharmaceuticals
1,983.00
203.84
11.46%
GB:HCM
HUTCHMED (China) Limited
337.00
119.00
54.59%
GB:DPH
3,866.00
224.00
6.15%
Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Pharma & Biotech Stocks Latest News

Currently, no data available
Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Pharma & Biotech Stocks

Name
Analyst
Analyst Firm
Rating
Price Target
Upside / Downside
Action
Date
GlaxoSmithKline
Buy
Reiterated
Hikma Pharmaceuticals
Hold
Reiterated
HUTCHMED (China) Limited
Buy
Initiated
GlaxoSmithKline
Buy
Reiterated
GlaxoSmithKline
Hold
Reiterated

Most Recent Earnings of Pharma & Biotech Stocks

Name
Report Date
Time Of Day
Period Ending
Forecast / EPS
Last Year's EPS
AstraZeneca
Apr 25, 2024
Mar 01, 2024
150.97 / 162.74
215
GlaxoSmithKline
May 01, 2024
Mar 01, 2024
36.70 / 43.10
38.8
Hikma Pharmaceuticals
Feb 22, 2024
Dec 01, 2023
- / 21.40
127.9
HUTCHMED (China) Limited
Feb 28, 2024
Dec 01, 2023
-17.06 / -11.06
1.924
DPH
- / -

Pharma & Biotech Stocks - FAQ

Which Pharma & Biotech stocks have a "Strong Buy" analyst rating?
These Pharma & Biotech stocks currently have a "Strong Buy" analyst rating consensus:
None of the selected stocks have a “Strong Buy” analyst rating consensus.
    Are Pharma & Biotech stocks overpriced?
    AstraZeneca's stock price is currently 12,081.00p, and its average 12-month price target is 12,295.99p.
      GlaxoSmithKline's stock price is currently 1,771.75p, and its average 12-month price target is 1,939.10p.
        Hikma Pharmaceuticals's stock price is currently 1,984.00p, and its average 12-month price target is 2,210.71p.
          HUTCHMED (China) Limited's stock price is currently 337.00p, and its average 12-month price target is 354.54p.
            's stock price is currently N/A, and its average 12-month price target is N/A.
              Which Pharma & Biotech stocks pay dividends?
              AstraZeneca does not currently pay dividends.
                GlaxoSmithKline does not currently pay dividends.
                  Hikma Pharmaceuticals does not currently pay dividends.
                    HUTCHMED (China) Limited does not currently pay dividends.
                      does not currently pay dividends.

                        Latest News​

                        Casey Dylan, CIMACamping World Holdings (NYSE:CWH) Prepares for an RV Market Recovery
                        Vince CondarcuriCleveland-Cliffs (NYSE:CLF) CEO Suggests U.S. Steel Deal Will Be Blocked
                        James FoxNvidia Stock (NASDAQ:NVDA): Is It a Buy at 71.3x Earnings?
                        Radhika SaraogiStock Market News Today, 5/17/24 – Indices Finish Mixed amid Rising Yields
                        Steve AndersonAnalyst Approval Gives Pinduoduo (NASDAQ:PDD) a Leg Up
                        Casey Dylan, CIMAStagwell (NASDAQ:STGW) Rides the Digital Advertising Wave
                        Steve AndersonApple (NASDAQ:AAPL) Working on Thinner iPhone. Investors Cheer.
                        Casey Dylan, CIMAIngevity (NYSE:NGVT): Profiting from the Green Transition
                        Steve AndersonNetflix (NASDAQ:NFLX) Proves It’s Beyond Just Movies
                        James FoxCathie Wood Abandons Twilio Stock (NASDAQ:TWLO): What to Make of It
                        Jonathan MorganGBP-USD Forecast: Trading Goldmine or Minefield?
                        Steve AndersonNew Intel (NASDAQ:INTC) Leaks Suggest New Chips Sooner than Later
                        Jonathan MorganEUR-USD Forecast: A Potential Long-Term Headache
                        Steve AndersonRedfin (NASDAQ:RDFN) Slips as It Expands Compensation
                        Vince CondarcuriPalo Alto Networks (NASDAQ:PANW) Pre-Earnings: Here’s What to Expect

                        Pharma & Biotech Stock Events

                        Stock
                        Type
                        Date
                        AstraZeneca
                        Earnings ReleaseJul 25, 2024
                        GlaxoSmithKline
                        Earnings ReleaseJul 31, 2024
                        HUTCHMED (China) Limited
                        Earnings ReleaseJul 31, 2024
                        Hikma Pharmaceuticals
                        Earnings ReleaseAug 08, 2024
                        Dechra Pharmaceuticals
                        Earnings ReleaseSep 02, 2024

                        Popular Stocks

                        Company
                        Price & Change
                        Follow
                        Nvidia
                        Apple
                        Microsoft